Use of immune checkpoint inhibitor (ICI) therapy for cancer was associated with a significant reduction in actinic keratoses ...
The FDA has updated the product labeling for Xeloda and 5-FU to highlight the risks associated with dihydropyrimidine ...
Dr. Gabriel A. Brooks discusses the recent FDA product labeling update for Xeloda and 5-FU which aims to highlight risks ...
To investigate the use of celecoxib on disease-free survival ... patients were randomized to receive adjuvant chemotherapy with fluorouracil, leucovorin, and oxaliplatin (FOLFOX) for three or ...
Data was used from the Framingham Heart Study and ... perioperative chemotherapy with what's called FLOT -- i.e., fluorouracil, leucovorin, oxaliplatin, and docetaxel -- plus surgery, or ...
While most cancer research focuses on discovering new treatments, Dr Nicky Lawrence and Professor Nuala Helsby from Waipapa Taumata Rau, University of Auckland, and Auckland Hospital oncologist Dr ...
Completion of SON-1010 (IL12-FHAB) monotherapy dose escalation in Phase 1 SB101 trial; Stable disease (SD) at four months post-initiation of ...
The drugs used to treat cancer damage healthy cells ... 8%), or the FOLFOX combination of folinic acid plus 5-fluorouracil plus oxalplatin (5; 6.5%). Pooled data analysis of the study results ...